Alentorn-Geli Eduard, Wanderman Nathan R, Assenmacher Andrew T, Sperling John W, Cofield Robert H, Sánchez-Sotelo Joaquín
Department of Orthopaedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
J Orthop Surg (Hong Kong). 2018 May-Aug;26(2):2309499018768570. doi: 10.1177/2309499018768570.
To compare the outcomes of total shoulder arthroplasty (TSA) with posterior capsule plication (PCP) and reverse shoulder arthroplasty (RSA) in patients with primary osteoarthritis, posterior subluxation, and bone loss (Walch B2).
All shoulders undergoing anatomic TSA with PCP were retrospectively identified (group 1, G1) and compared to shoulders undergoing RSA (group 2, G2) for Walch B2 osteoarthritis. There were 15 patients in G1 (mean (SD) age and follow-up of 70.5 (7.5) years and 42.8 (18.4) months, respectively) and 16 patients in G2 (mean (SD) age and follow-up of 72.6 (5.4) years and 35.1 (14.2) months, respectively).
Both groups had substantial improvements in pain and function. In G1, results were excellent in 80% and satisfactory in 20%, compared to 81% and 6% in G2, respectively ( p = 0.2). The mean (SD) American Shoulder and Elbow Surgeons score was 91.2 (6.7) and 80.3 (14.3) in G1 and G2, respectively ( p = 0.08). The mean Simple Shoulder Test score was 10.6 in G1 and 8.5 in G2 ( p = 0.01). There were no reoperations in either group, but G1 had seven postoperative complications.
The outcomes of TSA with PCP are comparable to RSA in patients with osteoarthritis and biconcave glenoids. However, TSA leads to more complications while RSA leads to lower functional outcomes.
比较全肩关节置换术(TSA)联合后关节囊折叠术(PCP)与反式肩关节置换术(RSA)治疗原发性骨关节炎、后脱位及骨质流失(Walch B2型)患者的疗效。
回顾性纳入所有接受解剖型TSA联合PCP的肩关节(第1组,G1组),并与接受RSA治疗Walch B2型骨关节炎的肩关节(第2组,G2组)进行比较。G1组有15例患者(平均(标准差)年龄和随访时间分别为70.5(7.5)岁和42.8(18.4)个月),G2组有16例患者(平均(标准差)年龄和随访时间分别为72.6(5.4)岁和35.1(14.2)个月)。
两组患者的疼痛和功能均有显著改善。G1组中,80%的结果为优,20%为良,而G2组分别为81%和6%(p = 0.2)。G1组和G2组美国肩肘外科医师协会评分的平均值(标准差)分别为91.2(6.7)和80.3(14.3)(p = 0.08)。G1组简单肩关节测试评分的平均值为10.6,G2组为8.5(p = 0.01)。两组均无再次手术,但G1组有7例术后并发症。
对于骨关节炎和双凹形肩胛盂患者,TSA联合PCP的疗效与RSA相当。然而,TSA导致更多并发症,而RSA导致更低的功能结果。